Clinical Trials · NCT05574439

Young Adults With Early-onset Obesity Treated With Semaglutide

CompletedPhase 4Semaglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Signe Torekov
Enrollment
246
Start date
May 2022
Locations
2 sites, Denmark
Primary endpoint
Change in BMI (weight in kg/height in m^2)
View Semaglutide compound reference